Aequs Limited (AEQUS), a leading India-based precision manufacturing company, today announced the signing of long-term supply agreements with Safran, a global leader in the aerospace industry for critical components. These agreements reflect the commitment of both companies to strengthen their collaboration and highlight Safran’s dedication to working with trusted, high-quality industrial partners.

Strengthening Aerospace Collaboration

The contracts will support Safran’s supply chain and ongoing production programs, while also contributing to the growth and development of Aequs within the aerospace sector. This milestone represents a significant opportunity for Aequs to further expand its activities alongside one of the world’s leading aerospace companies.

Expanding Manufacturing Capabilities

The agreements build on Aequs’ longstanding engagement with Safran Landing Systems and extend the relationship to Safran Aerosystems, broadening the scope of collaboration. The awards cover the machining of superalloys parts, along with the supply of complex machining coating, and assembly of landing gear components for the Airbus A320, A330, A350, and Boeing 787 programs. Aequs will leverage its integrated aerospace manufacturing ecosystem and end-to-end capabilities across forging, precision machining, special processes, surface treatment, and assembly to manufacture these products.

As a result, the role of Aequs’ Belagavi Aerospace Cluster as an integrated manufacturing base serving global aerospace supply chains will be further strengthened. This capability base will be expanded with the upcoming Aequs Engine Components Ecosystem (AECE) in Hosur, Tamil Nadu, where the manufacture of all medium and large parts will be taken up.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Aequs Limited

Aequs Limited belongs to the Industrials › Aerospace & Defense sector. Here’s a quick read on where the business and the stock stand today.

Aequs rises 9.9% over three months, with buying pressure holding steady. Margins at 12.4% are middling — adequate but leaving the business with little buffer against cost shocks. 4 loss quarters over five years is a serious red flag — earnings quality is poor and recovery is not guaranteed. The stock trades at 88% of its 52-week range — near its best levels of the year. Clearly, the market pays a premium for this name. Price climbs recently despite 14.8% revenue growth and a PEG of 99.00. Consequently, either institutions position ahead of improvement or the move fades when earnings disappoint. Treat this as a trading signal, not an investment thesis. Check Fundamentals of Aequs Limited.

Aequs Limited (AEQUS) has approved a preferential issue of up to 2,80,71,690 warrants, each convertible into one fully paid-up equity share of face value ₹10, to Mellwood Trustee Services Private Limited (Trustee of the Melligeri Private Family Foundation) (“Promoter”). This move aggregates to approximately ₹650 crore and is aimed at funding the company’s aerospace and consumer capacity expansion and supporting its borrowing program.

Significance of the Infusion

The proceeds from this infusion will fund capacity expansion across the aerospace and consumer businesses, including the development of the Hosur facility, investment in subsidiaries and joint ventures supporting that expansion, and general corporate purposes. The equity will also provide the base against which the company raises its term borrowings for the expansion. This infusion aligns the Promoter Group’s economic commitment with the company’s long-term growth plans and capital requirements.

Execution and Timeline

Of the total issue size of approximately ₹650 crore, ₹325 crore will be payable upfront upon allotment of the warrants, representing 50 per cent of the issue size, and twice the regulatory minimum. The balance will be payable upon exercise of the warrants. The warrants may be exercised within 18 months from the date of allotment. Conversion of warrants into equity shares, by making payment of balance consideration, shall take place on or before December 31, 2027. Promoter has undertaken to pay the balance consideration in full, irrespective of the market price of the company’s shares at the time of exercise.

An Extraordinary General Meeting is scheduled on Thursday, October 22, 2026, through video conferencing to seek shareholders’ approval. The detailed terms and conditions of the proposed issue, along with other relevant disclosures, will be made available to shareholders and filed with the stock exchanges in accordance with applicable laws and regulations.

Aravind Melligeri, Executive Chairman & CEO, Aequs Limited, said: “We are winning programmes faster than we had planned for, and those wins need investment ahead of the revenue they bring. This issue gives Aequs committed capital to build that capacity and the equity base to support the borrowing that goes with it. The Promoter Group is subscribing at the price as per SEBI pricing formula and paying half of it upfront — that is the measure of our confidence in what this business can deliver.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Aequs Limited

Aequs Limited belongs to the Industrials › Aerospace & Defense sector. Here’s a quick read on where the business and the stock stand today.

Aequs posts a 7.5% three-month gain, but softens in the last few weeks. Margins at 12.4% are middling — adequate but leaving the business with little buffer against cost shocks. 4 loss quarters over five years is a serious red flag — earnings quality is poor and recovery is not guaranteed. The stock gives back 2.2% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. The stock holds up despite 14.8% revenue growth and a PEG of 99.00. That could signal an early turnaround. Alternatively, index flows simply support the price. Watch whether analysts revise estimates upward — that is the real signal. Check Fundamentals of Aequs Limited.

Aequs Limited (AEQUS) gained +5% to near resistance at ₹253 on the NSE on 13 Aug 2026. The move comes as the stock tests the 6M resistance trendline, now just 1.1% away. Aequs, a player in the aerospace and defense sector, is showing strength despite the sector’s mixed performance, indicating that today’s move may be more company-specific than a broad sector rally.

Technical setup — trendlines & DMA

From a technical perspective, Aequs is currently trading above its 6M support trendline at ₹228.15, which is 8.75% below today’s price. The stock is approaching its 6M resistance trendline at ₹253, just 1.1% away. The 50-day moving average (DMA) at ₹224.6 is above the 200-DMA at ₹172.8, signaling a bullish trend. Aequs is currently in the upper third of its 52-week range, suggesting that a significant portion of its potential upside may already be priced in.

Fundamentals & business context

On the fundamental side, Aequs presents a mixed picture. With a revenue CAGR of 15.8% over the past 5 years but a profit CAGR of 0%, the company is growing its top line but not translating that into bottom-line growth. The -12.4% profit margin indicates thin profits, which could be a concern for value-oriented investors. Institutional ownership stands at 13.4%, suggesting that the ‘smart money’ is cautiously optimistic but not overly bullish. There was no specific NSE catalyst today, so the move appears to be driven by technical factors and overall sector sentiment.

Algorithmic scorecard

The algorithmic scorecard paints a picture of a stock that is technically strong but fundamentally weak. The strongest signals come from the bullish trend, with the 50-DMA above the 200-DMA, and the excellent year-to-date performance, which has seen the stock gain 59.1%. These indicators suggest that the stock has been accumulating strength over the past year. However, the weakest signals are the low profit margin of -12.4% and the company’s loss in the last quarter, which are red flags for fundamental investors. The negligible dividend yield of 0% also limits the income potential for yield-seeking investors.

Company outlook

Management provided an optimistic outlook for the full year, expecting 45% to 50% top-line revenue growth with a doubling of operational EBITDA. The consumer segment is expected to reach EBITDA breakeven by Q4 FY27, while the aerospace segment is targeted for 25% to 30% growth and the consumer segment for 125% to 150% growth over FY26. The company is also planning a significant capex of INR660 crores for FY27, with potential acceleration in aerospace capex, and a total capex plan of USD350 million to USD400 million from FY27 to FY31. These initiatives aim to ensure required capacity is available in line with customer timelines and to drive profitable growth in the aerospace segment.

Get all details on AEQUS — P&L, peers, shareholding and more on TradeAlone.